To address these critical safety requirements, BETMAT Biotechnology LLC has released a specialized operational guide focused on Reliable Endotoxin Testing For Injectable Pharmaceuticals, a systematic ...

When the sun set on May 31, 2017, in Cambria, Wisconsin, no one at Didion Milling's corn processing facility could have predicted the tragedy about to unfold. Hours later, a series of devastating ...

The AWS AI Agent Incidents This report reviews the breaking news about AWS AI outages, analyzes architectural failure modes, and demonstrates how ColorTokens Xshield microsegmentation, designed to ...

For the first time, researchers in China have demonstrated how quantum dots can be engineered to consistently generate pairs of entangled photons. By carefully tailoring the photonic environment ...

Researchers at the University of Edinburgh are working on engineering bacteria to convert chemicals derived from waste ...

Learn the details of the inventory receiving process, ways to streamline it, and how ShipBob can help improve receiving.

A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered hypertension and prevented serious disease or death for thousands of ...

Towards the normativity of AI-driven BCI technologies in product liability in healthcare,” published in AI & Society. In their research, the researchers analyze how emerging AI-driven ...

America has entered a moment in which it is fundamentally more vulnerable than at any point in modern history. For the first time, the systems that underpin economic prosperity, social stability and ...

Group regulatory expectations into a small set of stable control families and types, then run your program around those, not around clauses, articles and acronyms.

As AI campuses scale to gigawatt levels, the industry confronts a new execution challenge: aligning utilities, builders, and ...

Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...